Benzinga | Jun 15, 2021 03:34PM EDT

Cara Therapeutics Granted U.S. Patent Titled 'Oral formulations of kappa opioid receptor agonists'

https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=6620&f=G&l=50&d=PTXT&p=133&S1=20210615&OS=20210615&RS=20210615